Stock Analysts

Marathon Oil Abandons Oil Sands Stake Sale

Energy exploration and production firm Marathon Oil Corp. ( MRO ) has confirmed that it has pulled out of talks with potential buyers regarding the partial sale of its 20% interest in the Athabasca Oil Sands Project (AOSP) in Alberta, Canada. The venture – involved in the extraction of bitumen (a sticky, tar-like form of petroleum) from sand formations – is a collaboration between the Canadian subsidiaries of Europe’s largest oil company Royal Dutch Shell plc ( RDS.A ), U.S. […]

Stock Analysts

Mixed News on Merck’s Pipeline

Merck ( MRK ) recently announced mixed news on the pipeline front. While the company received support from the US Food and Drug Administration’s (FDA) Central Nervous System Drugs Advisory Committee for its insomnia candidate, suvorexant, Merck said that it will not pursue regulatory filings for its Parkinson’s disease candidate, preladenant. The company’s decision regarding preladenant was based on an initial review of data from three phase III studies which did not show evidence of efficacy compared to placebo. […]

Stock Analysts

Dow Eyeing $2 Billion Debt Cuts in 2013

The Dow Chemical Company ( DOW ) announced that it plans to use a part of a recent payment from the Petrochemical Industries Company of Kuwait (PIC) to pay down up to $2 billion in debt this year. Dow recently received $2.2 billion in cash as damages from PIC as the latter withdrew from a $17.4 billion joint venture ("K-Dow Petrochemicals") in 2008. Dow is looking for ways to reduce its debt and its actions are expected to deliver more than $100 million in annual interest expense savings once complete […]

Stock Analysts

Leadership Change at Airgas

Airgas, Inc. ( ARG ) has announced a change in the leadership of its South Division. Chuck Broadus will join the division as President, effective July 1, reporting to President and CEO of Airgas, Michael Molinini […]

Stock Analysts

EU Approval for Bayer/JNJ’s Xarelto

Bayer ’s ( BAYRY ) HealthCare segment recently received encouraging news when the European Commission approved its oral anticoagulant Xarelto (rivaroxaban) in combination with standard antiplatelet therapy. The combination is approved for the prevention of atherothrombotic events (myocardial infarction, cardiovascular death or stroke) after an acute coronary syndrome (ACS) in adults having elevated cardiac biomarkers. Bayer mentioned in its press release that with the approval, Xarelto became the only novel oral anticoagulant to be approved for the prevention of elevated cardiac biomarkers after an ACS event […]

Mergers & Acquisitions

NeoHydro Technologies Corp. Announces Letter of Intent to Acquire Couponz, Inc., Developer of Epoxy Mobile Application

NeoHydro Technologies Corp. Announces Letter of Intent to Acquire Couponz, Inc., Developer of Epoxy Mobile Application PR Newswire LAS VEGAS, May 28, 2013 LAS VEGAS , May 28, 2013 /PRNewswire/ — NeoHydro Technologies Corp. (OTC: NHYT) or (NeoHydro), a development stage company, today announced it has entered into a letter of intent to acquire Couponz, Inc., best known as the creator of the Epoxy mobile application […]

Mergers & Acquisitions

A. Schulman Announces an Agreement in Principle to Acquire Network Polymers, a Leading North American Niche Engineered Plastics Producer

A. Schulman Announces an Agreement in Principle to Acquire Network Polymers, a Leading North American Niche Engineered Plastics Producer PR Newswire AKRON, Ohio, May 28, 2013 AKRON, Ohio , May 28, 2013 /PRNewswire/ — Strengthens Company’s U.S. business position Provides complementary specialty business in ABS and ASA engineered plastics Expands U.S […]